Literature DB >> 35618829

Autoreactive CD8+ T cells are restrained by an exhaustion-like program that is maintained by LAG3.

Stephanie Grebinoski1,2,3, Qianxia Zhang1,2,3,4, Anthony R Cillo1,3, Sasikanth Manne5,6, Hanxi Xiao7,8, Erin A Brunazzi1,3, Tracy Tabib9, Carly Cardello1,3, Christine G Lian10, George F Murphy10, Robert Lafyatis9, E John Wherry5,6,11, Jishnu Das7, Creg J Workman1,3, Dario A A Vignali12,13,14.   

Abstract

Impaired chronic viral and tumor clearance has been attributed to CD8+ T cell exhaustion, a differentiation state in which T cells have reduced and altered effector function that can be partially reversed upon blockade of inhibitory receptors. The role of the exhaustion program and transcriptional networks that control CD8+ T cell function and fate in autoimmunity is not clear. Here we show that intra-islet CD8+ T cells phenotypically, transcriptionally, epigenetically and metabolically possess features of canonically exhausted T cells, yet maintain important differences. This 'restrained' phenotype can be perturbed and disease accelerated by CD8+ T cell-restricted deletion of the inhibitory receptor lymphocyte activating gene 3 (LAG3). Mechanistically, LAG3-deficient CD8+ T cells have enhanced effector-like functions, trafficking to the islets, and have a diminished exhausted phenotype, highlighting a physiological role for an exhaustion program in limiting autoimmunity and implicating LAG3 as a target for autoimmune therapy.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Year:  2022        PMID: 35618829      PMCID: PMC9179227          DOI: 10.1038/s41590-022-01210-5

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   31.250


  67 in total

1.  Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted.

Authors:  Jeremy S Tilstra; Lyndsay Avery; Ashley V Menk; Rachael A Gordon; Shuchi Smita; Lawrence P Kane; Maria Chikina; Greg M Delgoffe; Mark J Shlomchik
Journal:  J Clin Invest       Date:  2018-09-24       Impact factor: 14.808

2.  Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes.

Authors:  S Alice Long; Jerill Thorpe; Kevan C Herold; Mario Ehlers; Srinath Sanda; Noha Lim; Peter S Linsley; Gerald T Nepom; Kristina M Harris
Journal:  Cell Immunol       Date:  2017-08-18       Impact factor: 4.868

Review 3.  Defining 'T cell exhaustion'.

Authors:  Christian U Blank; W Nicholas Haining; Werner Held; Patrick G Hogan; Axel Kallies; Enrico Lugli; Rachel C Lynn; Mary Philip; Anjana Rao; Nicholas P Restifo; Andrea Schietinger; Ton N Schumacher; Pamela L Schwartzberg; Arlene H Sharpe; Daniel E Speiser; E John Wherry; Benjamin A Youngblood; Dietmar Zehn
Journal:  Nat Rev Immunol       Date:  2019-09-30       Impact factor: 53.106

4.  Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression.

Authors:  Alice E Wiedeman; Virginia S Muir; Mario G Rosasco; Hannah A DeBerg; Scott Presnell; Bertrand Haas; Matthew J Dufort; Cate Speake; Carla J Greenbaum; Elisavet Serti; Gerald T Nepom; Gabriele Blahnik; Anna M Kus; Eddie A James; Peter S Linsley; S Alice Long
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

5.  Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms.

Authors:  Jean-Christophe Beltra; Sasikanth Manne; Mohamed S Abdel-Hakeem; Makoto Kurachi; Josephine R Giles; Zeyu Chen; Valentina Casella; Shin Foong Ngiow; Omar Khan; Yinghui Jane Huang; Patrick Yan; Kito Nzingha; Wei Xu; Ravi K Amaravadi; Xiaowei Xu; Giorgos C Karakousis; Tara C Mitchell; Lynn M Schuchter; Alexander C Huang; E John Wherry
Journal:  Immunity       Date:  2020-05-11       Impact factor: 31.745

6.  TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion.

Authors:  Hyungseok Seo; Joyce Chen; Edahí González-Avalos; Daniela Samaniego-Castruita; Arundhoti Das; Yueqiang H Wang; Isaac F López-Moyado; Romain O Georges; Wade Zhang; Atsushi Onodera; Cheng-Jang Wu; Li-Fan Lu; Patrick G Hogan; Avinash Bhandoola; Anjana Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-31       Impact factor: 12.779

7.  T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection.

Authors:  Eoin F McKinney; James C Lee; David R W Jayne; Paul A Lyons; Kenneth G C Smith
Journal:  Nature       Date:  2015-06-29       Impact factor: 49.962

8.  Single-cell RNA-seq reveals TOX as a key regulator of CD8+ T cell persistence in chronic infection.

Authors:  Chen Yao; Hong-Wei Sun; Neal E Lacey; Yun Ji; E Ashley Moseman; Han-Yu Shih; Elisabeth F Heuston; Martha Kirby; Stacie Anderson; Jun Cheng; Omar Khan; Robin Handon; Julie Reilley; Jessica Fioravanti; Jinhui Hu; Selamawit Gossa; E John Wherry; Luca Gattinoni; Dorian B McGavern; John J O'Shea; Pamela L Schwartzberg; Tuoqi Wu
Journal:  Nat Immunol       Date:  2019-06-17       Impact factor: 25.606

9.  TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion.

Authors:  Omar Khan; Josephine R Giles; Sierra McDonald; Sasikanth Manne; Shin Foong Ngiow; Kunal P Patel; Michael T Werner; Alexander C Huang; Katherine A Alexander; Jennifer E Wu; John Attanasio; Patrick Yan; Sangeeth M George; Bertram Bengsch; Ryan P Staupe; Greg Donahue; Wei Xu; Ravi K Amaravadi; Xiaowei Xu; Giorgos C Karakousis; Tara C Mitchell; Lynn M Schuchter; Jonathan Kaye; Shelley L Berger; E John Wherry
Journal:  Nature       Date:  2019-06-17       Impact factor: 49.962

10.  TOX is a critical regulator of tumour-specific T cell differentiation.

Authors:  Andrew C Scott; Friederike Dündar; Paul Zumbo; Smita S Chandran; Christopher A Klebanoff; Mojdeh Shakiba; Prerak Trivedi; Laura Menocal; Heather Appleby; Steven Camara; Dmitriy Zamarin; Tyler Walther; Alexandra Snyder; Matthew R Femia; Elizabeth A Comen; Hannah Y Wen; Matthew D Hellmann; Niroshana Anandasabapathy; Yong Liu; Nasser K Altorki; Peter Lauer; Olivier Levy; Michael S Glickman; Jonathan Kaye; Doron Betel; Mary Philip; Andrea Schietinger
Journal:  Nature       Date:  2019-06-17       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.